These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 14457165

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The Food and Drug Administration; our mutual responsibility.
    HOLLAND AH.
    N Y State J Med; 1955 Aug 15; 55(16):2327-30. PubMed ID: 13244856
    [No Abstract] [Full Text] [Related]

  • 3. Understanding the regulation of pharmaceutical drug promotion [Editorial].
    Krane NA, Sataloff RT.
    Ear Nose Throat J; 2014 Dec 15; 93(12):486-8. PubMed ID: 25531838
    [No Abstract] [Full Text] [Related]

  • 4. Senator proposes drug shortages law.
    Thompson CA.
    Am J Health Syst Pharm; 2011 Mar 15; 68(6):461. PubMed ID: 21378289
    [No Abstract] [Full Text] [Related]

  • 5. 1992 Le Tourneau Award. Problems with pharmaceutical regulation in the United States. Drug lag and orphan drugs.
    Henry V.
    J Leg Med; 1993 Dec 15; 14(4):617-39. PubMed ID: 8308452
    [No Abstract] [Full Text] [Related]

  • 6. Pharmaceuticals and medical devices: FDA oversight.
    Health Policy Tracking Service, a service of Thomson Reuters Accelus, Berry MD.
    Issue Brief Health Policy Track Serv; 2012 Jan 03; ():1-86. PubMed ID: 22403845
    [No Abstract] [Full Text] [Related]

  • 7. U.S. v. Barr Laboratories: a technical perspective.
    Madsen RE.
    PDA J Pharm Sci Technol; 1994 Jan 03; 48(4):176-9. PubMed ID: 7804814
    [No Abstract] [Full Text] [Related]

  • 8. The "reverse payment paradox": an overview of the legality of reverse exclusionary payments in the pharmaceutical industry.
    Brockmeier MS.
    Health Care Law Mon; 2010 Mar 03; 2010(3):2-10. PubMed ID: 20329564
    [No Abstract] [Full Text] [Related]

  • 9. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J.
    Food Drug Law J; 2003 Mar 03; 58(4):629-48. PubMed ID: 15027454
    [No Abstract] [Full Text] [Related]

  • 10. FDA regulations and guidelines.
    Rothschild A.
    J Parenter Sci Technol; 1990 Mar 03; 44(1):26-9. PubMed ID: 2313489
    [No Abstract] [Full Text] [Related]

  • 11. Lawsuits anticipated on generic biologicals front.
    Fox JL.
    Nat Biotechnol; 2003 Jul 03; 21(7):721-2. PubMed ID: 12833078
    [No Abstract] [Full Text] [Related]

  • 12. Pharmaceutical postmarket review: fact or fiction?
    Schanz SJ.
    Food Drug Law J; 2007 Jul 03; 62(3):493-500. PubMed ID: 17915391
    [No Abstract] [Full Text] [Related]

  • 13. Drug shortage crisis resolution.
    Duffy E.
    J Pharm Pract; 2012 Dec 03; 25(6):619-20. PubMed ID: 23222856
    [No Abstract] [Full Text] [Related]

  • 14. The learned intermediary doctrine: past, present and future.
    Alsobrook HB.
    Leg Med; 1994 Dec 03; ():269-80. PubMed ID: 7830482
    [No Abstract] [Full Text] [Related]

  • 15. A strike against preemption.
    Nat Biotechnol; 2009 May 03; 27(5):397. PubMed ID: 19430422
    [Abstract] [Full Text] [Related]

  • 16. Report suggests steps to improve safety of drug supply.
    Traynor K.
    Am J Health Syst Pharm; 2011 Sep 01; 68(17):1570, 1574. PubMed ID: 21856799
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.